Target intelligence / Profile preview

Major allergen Ole e 1 (Ole e 1)

Target
Ole e 1
Molecular classification
Allergen, Glycoprotein, Ole e 1-like protein family
01

Overview

Ole e 1 is the primary major allergen found in the pollen of the olive tree (Olea europaea) and serves as the prototype for the Ole e 1-like protein family, which includes homologous allergens from other Oleaceae species such as ash, privet, and lilac (UniProt: P19963). Biologically, these proteins are glycoproteins believed to play a crucial role in pollen germination and pollen tube growth (PMID: 15585361). In clinical medicine, Ole e 1 is a potent inducer of Type I hypersensitivity, responsible for allergic rhinitis and asthma in a large percentage of the population in Mediterranean regions (PMID: 25533353). The allergen acts by binding to specific IgE antibodies on the surface of mast cells and basophils, triggering the release of histamine and other inflammatory mediators. Therapeutic management includes allergen-specific immunotherapy (AIT), which uses controlled doses of the allergen to promote immune tolerance and shift the immune response from a Th2 to a Th1/Treg profile. Additionally, biological therapies like Omalizumab are used to block the IgE-mediated pathway, effectively preventing the allergen from initiating the allergic cascade (WHO/IUIS Allergen Nomenclature).

Other names
Olive pollen allergen Ole e 1Ole e 1-like proteinOleaceae major allergenOlea europaea allergen 1
02

Mechanism of action

Allergen-specific immunotherapy (AIT) utilizes standardized extracts of Ole e 1 to induce immune tolerance by promoting the production of regulatory T cells and allergen-specific IgG4 antibodies. Monoclonal antibodies like Omalizumab bind to circulating IgE, preventing the allergen from cross-linking IgE on the surface of mast cells and basophils.

03

Biological functions

Pollen germinationPollen tube growthIgE bindingImmune response induction
04

Disease associations

Allergic rhinitisAsthmaType I hypersensitivityPollinosis
05

Safety considerations

Risk of anaphylaxis during immunotherapySystemic allergic reactionsLocal injection site reactions
06

Interacting drugs

Olive pollen extract

2 more in the full profile.

07

Biomarkers

Ole e 1-specific IgE (sIgE) levelsSkin prick test (SPT) reactivityBasophil activation test (BAT)

Beyond the preview

Go deeper on Major allergen Ole e 1 (Ole e 1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major allergen Ole e 1 (Ole e 1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call